Drugs / hFSH-HP
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02785822 Comparator | Feb 2017 → May 2018 | polycystic ovary syndrome | Sant Pau Research Institute | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hFSH-HP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02785822 ↗ |